Disease | severe combined immunodeficiency |
Phenotype | C0022116|ischemia |
Sentences | 1 |
PubMedID- 22247454 | Purpose: to determine long-term safety of intravitreal administration of good manufacturing practice (gmp)-grade human bone-marrow-derived cd34(+) cells in nod-scid (nonobese diabetic-severe combined immunodeficiency) mice with acute retinal ischemia-reperfusion injury, a model for retinal vasculopathy. |
Page: 1